Masimo (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors.

For over 35 years, Masimo has developed innovative monitoring technologies designed to improve patient outcomes and streamline clinical workflows. From the NICU to the operating room to the …

Masimo offers multiple advanced noninvasive and continuous monitoring technologies, available on a single integrated platform and on select third-party multi-parameter monitors.

If you are interested in learning more about Masimo's products and how to order them, please click here to be taken to our Product Information Request form, or use the list on this page to find contact …

We invented Masimo Signal Extraction Technology ® (Masimo SET ®) which for the first time, allowed pulse oximeters to provide accurate measurements even during patient motion and low perfusion …

Jan 21, 2025 · Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative …

Masimo wearable devices provide freedom for patients and clinicians alike, eliminating physical connections without sacrificing the power of clinically proven Masimo continuous monitoring.

Nov 4, 2025 · 20 minutes minimum delay | January 07, 2026 | 4:00 PM

Jan 9, 2025 · GE HealthCare (Nasdaq: GEHC) and Masimo (Nasdaq: MASI) today announced a joint agreement to integrate Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE …

Feb 25, 2025 · Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended December 28, 2024 and provided updated estimates for its full-year 2025 guidance.